Uncategorized · PP-SS31
SS-31 (10mg)
from $45.00
* Fulfillment subject to stock availability
For research purposes only.This compound is intended strictly for in-vitro laboratory research conducted by qualified professionals. It is not a drug, supplement, cosmetic, or food. It is not intended for use in or on humans or animals and has not been evaluated by the FDA for any purpose.
Mitochondrial Antioxidant Peptide · 10mg
SS-31 (Elamipretide) Protocol Reference Protocol
Daily subcutaneous injection. Cardiolipin protection and cellular respiration research.
BAC Water Reconstitution
Dilution volume: Add 2 mL BAC water to a 10 mg vial.
Quick-Draw Equivalents:
10 Units0.10 mL = 500 mcg (0.5 mg)
20 Units0.20 mL = 1,000 mcg (1.0 mg)
40 Units0.40 mL = 2,000 mcg (2.0 mg)
Timing & Administration
☀️ Morning
Morning administration preferred to support daytime metabolic and cellular energy pathways.
🌙 Night
Acceptable if morning schedule is constrained.
Titration Schedule Guide
SS-31 targets the inner mitochondrial membrane and binds to cardiolipin. Research protocols evaluate daily subcutaneous dosing for 4 to 8 weeks.
| Phase | Dose | Draw Volume | Protocol Notes |
|---|---|---|---|
| Initial Phase | 500 mcg - 1 mg daily | 10-20 Units | Cellular tolerance and baseline mitochondrial response testing. |
| Full Protocol | 1 - 2 mg daily | 20-40 Units | Standard research dosing range for oxidative stress and bioenergetics. |
Cycle Protocol
4 to 8 week research cycles followed by a 4-week evaluation break.
Observed Side Effects
Mild injection site rednessOccasional headacheTransient dizziness
Safety Notice: Inspect solution for clarity before drawing. Store refrigerated after reconstitution.